These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

449 related items for PubMed ID: 9137910

  • 1. The behavioural effects of pramipexole, a novel dopamine receptor agonist.
    Maj J, Rogóz Z, Skuza G, Kołodziejczyk K.
    Eur J Pharmacol; 1997 Apr 11; 324(1):31-7. PubMed ID: 9137910
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Behavioural evidence that different neurochemical mechanisms underly stretching-yawning and penile erection induced in male rats by SND 919, a new selective D2 dopamine receptor agonist.
    Ferrari F, Pelloni F, Giuliani D.
    Psychopharmacology (Berl); 1993 Apr 11; 113(2):172-6. PubMed ID: 7855178
    [Abstract] [Full Text] [Related]

  • 4. The activity of pramipexole in the mouse forced swim test is mediated by D2 rather than D3 receptors.
    Siuciak JA, Fujiwara RA.
    Psychopharmacology (Berl); 2004 Sep 11; 175(2):163-9. PubMed ID: 14985923
    [Abstract] [Full Text] [Related]

  • 5. Effects of the D3 preferring dopamine agonist pramipexole on sleep and waking, locomotor activity and striatal dopamine release in rats.
    Lagos P, Scorza C, Monti JM, Jantos H, Reyes-Parada M, Silveira R, Ponzoni A.
    Eur Neuropsychopharmacol; 1998 May 11; 8(2):113-20. PubMed ID: 9619689
    [Abstract] [Full Text] [Related]

  • 6. Motor actions of 7-OH-DPAT in normal and reserpine-treated mice suggest involvement of both dopamine D2 and D3 receptors.
    Starr MS, Starr BS.
    Eur J Pharmacol; 1995 Apr 24; 277(2-3):151-8. PubMed ID: 7493603
    [Abstract] [Full Text] [Related]

  • 7. Partial agonistic action of clozapine at dopamine D2 receptors in dopamine depleted animals.
    Ninan I, Kulkarni SK.
    Psychopharmacology (Berl); 1998 Feb 24; 135(3):311-7. PubMed ID: 9498736
    [Abstract] [Full Text] [Related]

  • 8. Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors.
    Svensson K, Carlsson A, Huff RM, Kling-Petersen T, Waters N.
    Eur J Pharmacol; 1994 Oct 03; 263(3):235-43. PubMed ID: 7843260
    [Abstract] [Full Text] [Related]

  • 9. Dopamine receptor antagonist properties of S 14506, 8-OH-DPAT, raclopride and clozapine in rodents.
    Protais P, Chagraoui A, Arbaoui J, Mocaër E.
    Eur J Pharmacol; 1994 Dec 12; 271(1):167-77. PubMed ID: 7698199
    [Abstract] [Full Text] [Related]

  • 10. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G, Depoortere R, Morel E, Sanger DJ, Scatton B.
    J Pharmacol Exp Ther; 1997 Jan 12; 280(1):73-82. PubMed ID: 8996184
    [Abstract] [Full Text] [Related]

  • 11. Dual motor response to l-dopa and nociceptin/orphanin FQ receptor antagonists in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) treated mice: Paradoxical inhibition is relieved by D(2)/D(3) receptor blockade.
    Viaro R, Marti M, Morari M.
    Exp Neurol; 2010 Jun 12; 223(2):473-84. PubMed ID: 20122926
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of dopamine neuron firing by pramipexole, a dopamine D3 receptor-preferring agonist: comparison to other dopamine receptor agonists.
    Piercey MF, Hoffmann WE, Smith MW, Hyslop DK.
    Eur J Pharmacol; 1996 Sep 19; 312(1):35-44. PubMed ID: 8891576
    [Abstract] [Full Text] [Related]

  • 13. D1 dopamine receptor activity of anti-parkinsonian drugs.
    Fici GJ, Wu H, VonVoigtlander PF, Sethy VH.
    Life Sci; 1997 Sep 19; 60(18):1597-603. PubMed ID: 9126882
    [Abstract] [Full Text] [Related]

  • 14. Involvement of dopamine receptors of the dorsal hippocampus on the acquisition and expression of morphine-induced place preference in rats.
    Rezayof A, Zarrindast MR, Sahraei H, Haeri-Rohani A.
    J Psychopharmacol; 2003 Dec 19; 17(4):415-23. PubMed ID: 14870954
    [Abstract] [Full Text] [Related]

  • 15. Talipexole or pramipexole combinations with chloro-APB (SKF 82958) in MPTP-induced hemiparkinsonian monkeys.
    Domino EF, Ni L, Zhang H, Kohno Y, Sasa M.
    Eur J Pharmacol; 1997 May 01; 325(2-3):137-44. PubMed ID: 9163560
    [Abstract] [Full Text] [Related]

  • 16. S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: II. Actions in rodent, primate, and cellular models of antiparkinsonian activity in comparison to ropinirole.
    Millan MJ, Di Cara B, Hill M, Jackson M, Joyce JN, Brotchie J, McGuire S, Crossman A, Smith L, Jenner P, Gobert A, Peglion JL, Brocco M.
    J Pharmacol Exp Ther; 2004 Jun 01; 309(3):921-35. PubMed ID: 14978195
    [Abstract] [Full Text] [Related]

  • 17. Neuroprotective effects of the novel D3/D2 receptor agonist and antiparkinson agent, S32504, in vitro against 1-methyl-4-phenylpyridinium (MPP+) and in vivo against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a comparison to ropinirole.
    Joyce JN, Presgraves S, Renish L, Borwege S, Osredkar T, Hagner D, Replogle M, PazSoldan M, Millan MJ.
    Exp Neurol; 2003 Nov 01; 184(1):393-407. PubMed ID: 14637109
    [Abstract] [Full Text] [Related]

  • 18. The anticataleptic effect of 7-OH-DPAT: are dopamine D3 receptors involved?
    Maj J, Rogóz Z, Skuza G.
    J Neural Transm (Vienna); 1999 Nov 01; 106(11-12):1063-73. PubMed ID: 10651103
    [Abstract] [Full Text] [Related]

  • 19. Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors.
    Mierau J, Schneider FJ, Ensinger HA, Chio CL, Lajiness ME, Huff RM.
    Eur J Pharmacol; 1995 Jun 23; 290(1):29-36. PubMed ID: 7664822
    [Abstract] [Full Text] [Related]

  • 20. Food restriction alters N'-propyl-4,5,6,7-tetrahydrobenzothiazole-2,6-diamine dihydrochloride (pramipexole)-induced yawning, hypothermia, and locomotor activity in rats: evidence for sensitization of dopamine D2 receptor-mediated effects.
    Collins GT, Calinski DM, Newman AH, Grundt P, Woods JH.
    J Pharmacol Exp Ther; 2008 May 23; 325(2):691-7. PubMed ID: 18305018
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.